Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Sugammadex and Neostigmine in Terms of Awakening, Pain, Agitation, Nausea and Vomiting in Pediatric Patients''

NCT05618236 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT05618236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Sugammadex and Neostigmine in Terms of Awakening, Pain, Agitation, Nausea and Vomiting in Pediatric Patients''
Lead sponsor
Marmara University
Phase
Observational
Overall status
Completed
Start date
November 8, 2022
Completion date
April 15, 2024
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative delirium, postoperative nausea, postoperative vomiting